Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.5.0.2
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Payables and Accruals [Abstract]    
Accrued clinical operations and trials costs $ 1,537,459 $ 365,188
Accrued product development costs 664,930 152,018
Accrued other 140,463 45,073
Total $ 2,342,852 $ 562,279